120 results
Glucose-lowering medication in type 2 diabetes - Algorithm

#Diabetes #Medications #Algorithm #Pharmacology #Pharmacotherapy #Hypoglycemic #Management #Endocrinology
medication in type 2 diabetes ... - Algorithm # ... Diabetes #Medications ... #Algorithm #Pharmacology ... Hypoglycemic #Management #Endocrinology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... #pharmacology #pharmacotherapy ... #endocrinology ... #treatment
Diabetes Pathophysiology and Medication Targets

The ominous octet is one concept that summarizes the different pathophysiologic pathways
Diabetes Pathophysiology ... and Medication ... medications and ... #Pathophysiology ... Targets #Drug #Endocrinology
Pathophysiology and Effects of Insulin Deficiency

#Insulin #Deficiency #DKA #Ketoacidosis #Diabetes #Pathophysiology #Endocrinology
Pathophysiology ... and Effects of Insulin ... #Ketoacidosis #Diabetes ... #Pathophysiology ... #Endocrinology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology ... • Euglycemic diabetic ... #Pharmacology # ... Summary #DM2 #diabetes ... #endocrinology
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... sarahthelyon #Diabetes ... #Medications #pharmacology ... #pathophysiology ... #endocrinology
Pharmacologic treatment of hyperglycemia in adults with type 2 diabetes

#Diabetes #Management #Algorithm #endocrinology #pharmacology #medications
Pharmacologic treatment ... adults with type 2 diabetes ... #Diabetes #Management ... #Algorithm #endocrinology ... #pharmacology #
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
Cardiovascular and ... between SGLT-2 inhibitors ... (Steglatro) #diabetes ... renal #SGLT2i #Inhibitors ... #pharmacology
Pathophysiology of Diabetic Ketoacidosis (DKA) and Hyperglycemic Hyperosmolar Syndrome (HHS)
Absolute Insulin deficit:
 - Type I DM:
Pathophysiology ... (DKA) and Hyperglycemic ... #dka #hhs #pathophysiology ... #comparison #endocrinology ... #diabetes #diabetic
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... - Pharmacology ... #Pharmacology # ... Summary #DM2 #diabetes ... #endocrinology